Fettah Acıbucu

Fettah Acıbucu

Auto-generated profile, based on publicly available information

Fettah Acıbucu

University of Health Sciences, Adana Health Practice and Research Center, Department of Endocrinology

Research Focus & Metrics

Academic Career Length

11Years (2016-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 November 2020 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
MBMehmet Bankir
Mehmet Bankir
CACansu Abayli
Cansu Abayli
FAFettah Acibucu
Fettah Acibucu
Objective: This study investigated whether ELABELA plays a role in the differential diagnosis of benign and malignant lesions of the thyroid gland. Subjects and methods: Of the 87 patients included in the study, 12 had undergone surgery for benign thyroid diseases, 30 had papillary thyroid cancer without invasion and/or lymph node metastasis in the surrounding tissues in the pathology report, and 45 had papillary thyroid cancer with invasion and/or lymph node metastasis in the surrounding tissues. Results: In the macrocarcinoma group, the proportion of patients with severe ELABELA staining (61.1%) was higher than that in the adenoma (50%) and microcarcinoma (23.8%) groups, while the proportion of those with mild to moderate staining was lower (p < 0.001). In the microcarcinoma group, the proportion of patients with severe staining was lower than that in the adenoma group, while the proportion of those with mild to moderate staining was higher (p <0.001). In papillary thyroid carcinomas, the rates of moderate and severe staining in the classical variant, mild staining in the follicular variant, severe staining in the classical + follicular variant, and severe staining in the oncocytic variant were higher. Conclusion: To the best of our knowledge, this study is the first to be conducted on this subject. In this study, ELABELA was not found to be significant in the differential diagnosis of benign and malignant lesions of the thyroid gland. In papillary thyroid carcinomas, severe ELABELA staining patterns were more common in macrocarcinoma patients than in microcarcinoma patients.

3 July 2020 in The European Research Journal
Verified
Journal Article
Open access
PDF file
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
FAFettah Acıbucu
Fettah Acıbucu
Objectives: As the treatment approaches of Graves’ disease and thyroiditis are different, differential diagnosis is important. In this study, we analyzed whether it is possible to perform a differential diagnosis for these two conditions by checking the increase ratio of free thyroid hormones.Methods: In total 156 patients were taken into this study of which 29 were thyroiditis (17 had subacute thyroiditis, 6 had post-partum and 6 had silent thyroiditis) and 127 were Graves patients. The age, free T3 (FT3), free T4 (FT4), thyroid stimulating hormone (TSH) levels, FT3 index (FT3/FT3 upper limit of normal (ULN)), FT4 index (FT4/FT4 ULN) and free thyroid hormone index (FTHI) (FT3 index/FT4 index) of all patients were determined.Results: A significant difference was found between the mean TSH, FT3 and FT3 index between Graves’ disease and thyroiditis (p = 0.036, p = 0.001 and p =0.001, respectively). When the groups were compared in terms of FTHI, the difference was found statistically significant (p = 0.001). FTHI was above 1 in all patients with Graves’ disease whereas it was found below 1 in all patients with thyroiditis. There were no statistically significant difference between the Graves’ disease and the thyroiditis in terms of age, FT4 and FT4 index (p = 0.748, p = 0.389 and p = 0.392, respectively).Conclusion: Based on these results, considering the increases in free thyroid hormone values we can say that it is possible to perform a differential diagnosis of Graves’ disease and thyroiditis, and that this may be used as a practical method to differentiate these two conditions.

23 March 2022 in Archives of Endocrinology and Metabolism
Verified
Journal Article
Open access
PDF file
FAFettah Acibucu
Fettah Acibucu
DODilan Damla Ozturk
Dilan Damla Ozturk
CKCisem Kizildag
Cisem Kizildag
MAMuhammed Zubeyir Aslan
Muhammed Zubeyir Aslan
EGErdinc Gulumsek
Erdinc Gulumsek
Hilmi Erdem SumbulHilmi Erdem Sumbul
Hilmi Erdem Sumbul
Objective: Graves’ ophthalmopathy (GO) is a vision-threatening finding observed in approximately half of Graves’ disease patients. The pathophysiology of GO is unclear, and one of the suspected factors is oxidative stress. In our study, we compared the relationship between proptosis and SH-SS in patients diagnosed with GO. Materials and methods: In this prospective study, 40 recently diagnosed Graves’ disease patients with proptosis, 40 recently diagnosed Graves’ disease patients without GO and 30 healthy individuals with similar demographic characteristics were [...] ABSTRACT Objective: Graves’ ophthalmopathy (GO) is a vision-threatening finding observed in approximately half of Graves’ disease patients. The pathophysiology of GO is unclear, and one of the suspected factors is oxidative stress. In our study, we compared the relationship between proptosis and SH-SS in patients diagnosed with GO. Materials and methods: In this prospective study, 40 recently diagnosed Graves’ disease patients with proptosis, 40 recently diagnosed Graves’ disease patients without GO and 30 healthy individuals with similar demographic characteristics were

25 November 2016 in Cumhuriyet Medical Journal
Verified
Journal Article
Closed access
FAFettah Acıbucu
Fettah Acıbucu
HDHatice Sebila Dökmetaş
Hatice Sebila Dökmetaş
FKFatih Kılıçlı
Fatih Kılıçlı
CÇCem Çelik
Cem Çelik
MAMustafa Aydemir
Mustafa Aydemir
SUMMARY Objective : To investigate the relationship between autoimmune thyroid disease and vitamin D treatment. Method : Fifty four (54) patients with both vitamin D deficiency and newly diagnosed euthyroid Hashimoto’s thyroiditis (HT) were recruited for this study. The patients were given intramuscular administration of cholecalciferol at a dose of 300,000 IU/month for 3 months. At the time of diagnoses and after the treatment of vitamin D, free T3 (FT3), free T4 (FT4), thyroid stimulating hormone (TSH), antithyroid peroxidase (anti-TPO), antithyroglobulin (anti-TG), 25 (OH) D3, parathormone (PTH), calcium (Ca), phosphorus (P) and alkaline phosphatase (ALP) levels were measured in all patients; TNF-a, IL-6 and IL-1ß levels were measured in only 43 patients. Results: A statistically significant difference (p˂0.05) was observed between the pre and post treatment FT4, TSH, antiTPO, antiTG, PTH and ALP levels. After the treatment of vitamin D, a statistically significant increase was found in 25 (OH) D3 and FT4 levels, and a significant decrease was found in TSH, antiTPO, antiTG, PTH and ALP levels, whereas no significant difference was noted in FT3, Ca, P, TNF- a, IL-6 and IL-1ß levels. Further, levels of vitamin D were not correlated with FT3, FT4, TSH, antiTPO, antiTG, TNF-a, IL-6 and IL-1ß levels (p˃0.05). Conclusions: For patients with both vitamin D deficiency and newly diagnosed HT, treatment of vitamin D had a positive effect on the thyroid antigenicity and thyroid function. Keywords: Autoimmune thyroid disease, Hashimoto's thyroiditis, Vitamin D deficiency ÖZET Amaç: D vitamini tedavisinin otoimmun tiroid hastalığı ile ilişkisini araştırdık. Yöntem: Çalışmaya D vitamini yetersizliği ve beraberinde yeni tanı alan Hashimoto tiroiditi olan (HT) 54 hasta alındı. Hastalara 3 ay süreyle ayda bir 300.000 IU kolekalsiferol intramuskuler olarak verildi. Tanı esnasında ve D vitamini tedavisi sonrasında serbest T3(FT3), serbest T4 (FT4), tiroid stimulan hormon (TSH), anti tiroid peroksidaz (TPO) ve anti tiroglobulin (TG), 25(OH)D3, parathormon (PTH), kalsiyum (Ca), fosfor (P) ve alkalen fosfataz (ALP) seviyeleri ve yalnız 43 hastada TNF- α, IL-6, IL-1b seviyeleri ölçüldü. Bulgular: Tedavi öncesi ve sonrası FT4, TSH, antiTPO, antiTG, PTH ve ALP seviyeleri açısından arada istatistiksel olarak anlamlı fark vardı (p<0.05). D vitamini tedavi sonrasında 25 (OH) D3 ve FT4 seviyelerinde istatiksel olarak önemli bir artış olurken TSH, antiTPO, antiTG, PTH ve ALP seviyelerinde ise önemli bir düşüş gözlendi. FT3, Ca, P, TNF- α, IL-6 ve IL-1b açısından önemli bir fark yoktu. D vitamini seviyesi ile FT3, FT4, TSH, antiTPO, antiTG, TNF- α, IL-6 ve IL-1b arasında bir korelasyon yoktu. Sonuç: D vitamini eksikliği ve yeni tanı HT’i olan hastalarda D vitamini tedavisinin tiroid antijenitesi ve tiroid fonksiyonu üzerine olumlu yönde etkisi vardır. Anahtar sözcükler: Otoimmun tiroid hastalığı, Hashimoto tiroiditi, D vitamini yetersizliği

28 March 2016 in Cumhuriyet Medical Journal
Verified
Journal Article
Open access
PDF file
FAFettah Acıbucu
Fettah Acıbucu
MTMeryem Timuçin
Meryem Timuçin
DADuygu Oğuz Acıbucu
Duygu Oğuz Acıbucu
SUMMARY Insulin autoimmune syndrome (IAS) is a disease characterized by hypoglycemia and insulin antibodies without insulin usage. We report the case of a patient diagnosed with IAS that was associated with the use of thiocolchicoside. A 62-year-old female patient was admitted to our clinic with fasting and postprandial hypoglycemia symptoms. She had a fasting glucose level of 47mg/dl, and high insulin, C-peptide and insulin antibody levels were detected. However, she had no signs of hypoglycemia during a 72 hour fasting test. In addition, the patient had used thiocolchicoside for a week a month prior to the beginning of her symptoms, but she was not taking any insulin or diabetic medications. A diagnosis of IAS was made, and the patient was put on an appropriate diet. Three months following this diagnosis, the patient’s complaints have minimilized, and the insulin and C-peptide levels have decreased. Keywords: Insulin autoimmune syndrome, hypoglycemia, thiocolchicoside ÖZET İnsülin otoimmun sendromu (IAS) hipoglisemi ve insülin kullanmaksızın insülin antikorlarının varlığı ile karakterize nadir bir hastalıktır. Biz tiyokolşikosid kullanımına bağlı IAS tanısı koyduğumuz bir vakayı sunuyoruz. 62 yaşında bayan hasta açlıkta ve postprandial hipoglisemi semptomları ile başvurdu. Açlık kan şekeri 47mg/dl ve insülin, C peptid, insülin antikor düzeyi yüksek olarak tesbit edildi. 72 saat uzamış açlık testinde hipoglisemi yaşamadı. Şikayetlerinin başlamasından bir ay öncesinde bir hafta süreyle tiyokolşikosid kullanımı vardı, insülin ve diyabetik ilaç kullanımı yoktu. Hastaya insülin otoimmun sendromu tanısı kondu ve diyet tedavisi önerildi. Hastanın üç ay sonrasında şikayetleri azaldı insülin ve C peptid düzeyi düştü. Anahtar sözcükler: İnsülin otoimmun sendromu, hipoglisemi, tiyokolşikosid

1 June 2026 in Endocrinology Research and Practice
Verified
Journal Article
Open access
PDF file
MBMehmet Emin Bozdoğan
Mehmet Emin Bozdoğan
ŞKŞekure Demet Küçük
Şekure Demet Küçük
MDMerve Şimşek Dilli
Merve Şimşek Dilli
FAFettah Acıbucu
Fettah Acıbucu
EAElife Aşut
Elife Aşut
Nesidioblastosis represents a rare cause of endogenous hyperinsulinemic hypoglycemia in adults, characterized by diffuse or focal proliferation of pancreatic β-cells. It often mimics insulinoma clinically and radiologically, and therefore, its differential diagnosis is quite difficult in the preoperative period. A case of adult nesidioblastosis mimicking insulinoma is presented. A 59-year-old man with a 13-year history of type 2 diabetes mellitus presented with recurrent hypoglycemic episodes manifested by sweating, palpitations, and confusion, despite cessation of antidiabetic therapy for 2 months. During a prolonged fasting test, hypoglycemia accompanied by inappropriately elevated insulin and C-peptide concentrations confirmed endogenous hyperinsulinemia. Contrast-enhanced abdominal computed tomography (CT) and magnetic resonance imaging failed to reveal a pancreatic lesion. Gallium-68 DOTATATE positron emission tomography (68Ga-DOTATATE PET) demonstrated a focal area of increased uptake, approximately 1 cm in size, in the pancreatic uncinate process, suggesting a preliminary diagnosis of insulinoma. The patient underwent Whipple surgery, during which no macroscopic tumor was identified. Histopathological examination revealed ductuloinsular complexes, islet cell hyperplasia, and nuclear enlargement, and the findings were evaluated as compatible with focal nesidioblastosis. This case emphasizes the diagnostic complexity of differentiating nesidioblastosis from insulinoma and underscores the essential role of histopathological and immunohistochemical analyses for establishing a definitive diagnosis. Cite this article as: Bozdoğan ME, Kü.ük ŞD, Dilli MŞ, Acıbucu F, Aşut E. Adult-onset nesidioblastosis mimicking insulinoma in a patient with type 2 diabetes mellitus: A case report. Endocrinol Res Pract. 2026;30(3):209-212.